SCHEMBL22798409

SCHEMBL22798409

CCC(=O)Nc1cc(C(=O)NCCOc2ncc(C(F)(F)F)cc2C#N)cc(C)n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 3/20 0.61
KDM4E B2RXH2 1/20 0.35
GLA P06280 1/20 0.35
PTK2 Q05397 1/20 0.34
RHOC P08134 1/20 0.34
RHOA P61586 1/20 0.34
ACACB O00763 1/20 0.34
KMT2A Q03164 3/20 0.33
MALT1 Q9UDY8 2/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
PRKAB2 O43741 1/20 0.33
PRKAG1 P54619 1/20 0.33
PRKAA2 P54646 1/20 0.33
PRKAA1 Q13131 1/20 0.33
PRKAG3 Q9UGI9 1/20 0.33
PRKAG2 Q9UGJ0 1/20 0.33
PRKAB1 Q9Y478 1/20 0.33
MEN1 O00255 2/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20595155 0.88 SCN9A (0.65) SCN9APTK2RHOCRHOAKMT2A
SCHEMBL22798237 0.87 SCN9A (0.79) SCN9ARHOCRHOAKMT2ALMNA
SCHEMBL22797748 0.81 SCN9A (0.56) SCN9APRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL30449736 0.81 SCN9A (0.56) SCN9APRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL22798239 0.80 SCN9A (0.59) SCN9APTK2RHOCRHOACYP1A2
SCHEMBL22798435 0.79 SCN9A (0.53) SCN9AKDM4ERHOCRHOAKMT2A
SCHEMBL30449642 0.79 SCN9A (0.53) SCN9AKDM4ERHOCRHOAKMT2A
SCHEMBL20596679 0.78 SCN9A (0.55) SCN9ARHOCRHOA
SCHEMBL30450229 0.78 SCN9A (0.55) SCN9ARHOCRHOA
SCHEMBL22798304 0.78 SCN9A (0.82) SCN9AKDM4ERHOCRHOAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110612285-B Amide derivatives as Nav1.7 and Nav1.8 blockers 拉夸里亚创药株式会社 2023-04-04 CN claimed
EP-3487839-B1 AMIDE DERIVATIVES AS NAV1.7 AND NAV1.8 BLOCKERS RAQUALIA PHARMA INC (JP) 2020-12-23 EP claimed
CN-110612285-A Amide derivatives as Nav1.7 and Nav1.8 blockers 拉夸里亚创药株式会社 2019-12-24 CN claimed
CN-110612285-B Amide derivatives as Nav1.7 and Nav1.8 blockers 拉夸里亚创药株式会社 2023-04-04 CN disclosed
US-11154544-B2 Amide derivatives as Nav1.7 and Nav1.8 blockers RAQUALIA PHARMA INC. (JP) 2021-10-26 US disclosed
EP-3487839-B1 AMIDE DERIVATIVES AS NAV1.7 AND NAV1.8 BLOCKERS RAQUALIA PHARMA INC (JP) 2020-12-23 EP disclosed
CN-110612285-A Amide derivatives as Nav1.7 and Nav1.8 blockers 拉夸里亚创药株式会社 2019-12-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11154544-B2 Amide derivatives as Nav1.7 and Nav1.8 blockers SCN8A, SCN7A, SCN1A SCN9A 9/4885KDM4E 1418/4885GLA 3010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.